Gram positive antibiotics Flashcards
List of gram positive abx
vancomycin, daptomycin (Cubicin), quinupristin/dalfopristin (Synercid), linezolid (Zyvox), tedizolid (Sivextro), telavancin (Vibativ), dalbavancin (Dalvance), oritavancin (Orbactive)
MOA of vancomycin
glycopeptide, inhibits cell wall synthesis by binding to D alanin-D-alanine of peptidoglycan, slow bactericidal, time dependent
Spectrum of Vancomycin
DOC for MRSA, S pneumo, MSSA but not as good as B-lactams, enterococcus faecalis, E. faecium, listeria monocytogenes, corynebacterium, clostridia
Kinetics of vancomycin
very large, cannot be absorbed by GI, only IV for systemic therapy, PO for GI, very lipophilic, well distributed, too big to cross BBB so give high dose or use shunt
ADRs of vancomycin
renally eliminated, nephrotoxic usually reversible, ototoxicity with prolonged therapy, red man syndrome- not allergy, phlebitis
Dosing of vancomycin
pt specific requires intense monitoring, based on body wt
Clinical use of vancomycin
B-lactam allergy, c. diff, surgical prophylaxis, MRSA, febrile neurtopenia, UTI- low dose, osteomyelitis/septic arthritis/meningitis, SSTI
Vancomycin Pearls
potential S. aureus resistance in future, use with aminoglycosides, pip/tazo, nephrotoxic agent inc nephrotoxicity, used regularly for pt with ESRD
Quinupristin/Dalfopristin (Synercid) MOA
bind to 50S ribosome to inhibit protein synthesis, time dependent, bactericidal
Quinupristin/Dalfopristin (Synercid) spectrum
broad spectrum, used rarely
ADRs of quinupristin/Dalfopristin (Synercid)
hyperbilirubinemia, arthralgias
Clinical use of quinipristin/dalfopristin (Synercid)
VRE bacteremia, central line associated blood infxn, SSTI
DI of quinipristin/dalfopristin (Synercid)
many! why its usse is rare
Daptomycin (Cubicin) MOA
a cyclic lipoppetide, cell death gram + bacteria by binding to cell membrane and depolarizes loses ion, inhibits proteins, DNA, RNA, concentration dependent, rapid bactericidal
Spectrum Daptomycin (Cubicin)
staph (MRSA, VRSA etc), enterococcus (including VRE), stretpococci (penicillin resistant)
ADRs of Daptomycin (Cubicin)
very well tolerated, can give long term, myalgias- hold statin therapy, NVD
Clinical use of Daptomycin (Cubicin)
SSTI, bacteremia, endocarditis
What illness should not be treated w/ daptomycin
pneumonia
Dosage of Daptomycin (cubicin)
SSTI- 4mg/kg IV qd, bacteremia- 6-8mg/kg IV qd, endocarditis- 8 mg/kg IV qd
Linezolid (Zyvox) dosage
600 mg po BID
Linezolid (Zyvox) MOA
an oxazolidinone, bind to 50 S ribosome near the 30 S interface to inhibit protein synthesis, bacteriostatic, unique!
Linezolid (Zyvox) spectrum
MRSA, MSSA, MRSE, MSSE, little gram neg activity, strep- bactericidal, enterococcus (VRE)
ADRs of linezolid (zyvox)
NVD, thrombocytopenia with long term (>2 weeks)
DI of linezolid
Serotonin syndrome
Pearls of linezolid
IV and PO dose the same, not renally eliminated, $$$$
Clinical use of linezolid
pneumonia, SSTI, bacteremia- 3rd line
Tedizolid (sivextro) MOA
an oxazolidinone, binds 50S inhibit protein synthesis, bacteriostatic
Spectrum of Tedizolid (Sivextro)
staph (MSSA, MRSA), strep, entero faecalis
ADR of tedizolid (Sivextro)
NVD, hematologic rxn
Clinical use of tedizolid (Sivextro)
SSSI
Pearl of tedizolid (sivextro)
new, once daily, $$$
Telavancin (Vibativ) MOA
glycopeptide, inhibits cell wall synthesis by blocking polymerization of peptidoglycan D-A-D-A, concentration dependent
ADR of telavancin (Vibativ)
nephrotoxic, NV, metallic test
Telavancin (Vibatic) spectrum
staph (MRSA, MSSA), entero (VSE, faecalis), strept
Clinical use of telavancin (Vibatic)
SSSI, HAP, VAP
Dalbavancin (Dalvance) MOA
a glycopeptide, inhibit cell wall synthesis by forming a complex with D-A-D-A
Spectrum of dalbavancin (Dalvance)
MRSA, MSSA, linezolid resistant, strep including pcn resistant, enterococci not VRE, clostridia
Kinetics of dalbavancin (Dalvance)
8.5 day T1/2, once weekly dosing
Clinical use of dalbavancin (Dalvance)
acute bacterial SSSI
Pearls of dalbavancin (Dalvance)
Good ADR, $4500 for 2 doses
Oritavancin (Orbactiv) MOA
glycopeptide, T1/2 10 day
Spectrum of oritavancin (Orbactiv)
SSSI